Skip to main content

CORRECTION article

Front. Oncol., 22 September 2022
Sec. Cancer Molecular Targets and Therapeutics
Volume 12 - 2022 | https://doi.org/10.3389/fonc.2022.1032265

Corrigendum: TPX2 enhanced the activation of the HGF/ETS-1 pathway and increased the invasion of endocrine-independent prostate carcinoma cells

This article is a correction to:

  1. TPX2 Enhanced the Activation of the HGF/ETS-1 Pathway and Increased the Invasion of Endocrine-Independent Prostate Carcinoma Cells

    1. Read original article
Hongqing Zhou&#x;Hongqing Zhou1†Mingsheng Liu&#x;*Mingsheng Liu1†*Tao ShaoTao Shao1Pingbo XiePingbo Xie1Shaojie ZhuShaojie Zhu1Wei WangWei Wang1Qiong MiaoQiong Miao1Jiaxi PengJiaxi Peng1Peng Zhang*Peng Zhang2*
  • 1The Second Ward of Urology, Qujing Affiliated Hospital of Kunming Medical University, Qujing, China
  • 2Department of Urology, Chinese People’s Liberation Army (PLA) General Hospital/Chinese PLA Medical Academy, Beijing, China

A Corrigendum on
TPX2 enhanced the Activation of the HGF/ETS-1 pathway and increased the invasion of endocrine-Independent prostate carcinoma cells

by Zhou Q, Liu M, Shao T, Xie P, Zhu S, Wang W, Miao Q, Peng J and Zhang P (2021) 11:618540. doi: 10.3389/fonc.2021.618540

An author name was incorrectly spelled as Qinghong Zhou. The correct spelling is Hongqing Zhou.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: the targeting protein for Xklp2, prostate carcinoma, E26 transformation specific sequence 1, metastasis, endocrine-independent

Citation: Zhou H, Liu M, Shao T, Xie P, Zhu S, Wang W, Miao Q, Peng J and Zhang P (2022) Corrigendum: TPX2 enhanced the activation of the HGF/ETS-1 pathway and increased the invasion of endocrine-independent prostate carcinoma cells. Front. Oncol. 12:1032265. doi: 10.3389/fonc.2022.1032265

Received: 30 August 2022; Accepted: 31 August 2022;
Published: 22 September 2022.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2022 Zhou, Liu, Shao, Xie, Zhu, Wang, Miao, Peng and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Mingsheng Liu, MTg5MDg3NDE5ODFAMTg5LmNu; Peng Zhang, YWx3YXlzanVtcGVyQDEyNi5jb20=

†These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.